Telemetry Investments’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Telemetry Investments’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,046	Closed	-$552K	–	216
2022 Q2	$552K	Buy	+10,046	New	+$527K	0.65%	45
2021 Q3	–	Sell	-12,349	Closed	-$241K	–	179
2021 Q2	$241K	Sell	12,349 -8,432	-41%	-$153K	0.33%	90
2021 Q1	$358K	Sell	20,781 -1,568	-7%	-$24.8K	0.4%	83
2020 Q4	$358K	Buy	+22,349	New	+$310K	0.6%	61
2019 Q4	–	Sell	-19,669	Closed	-$307K	–	53
2019 Q3	$307K	Buy	19,669 +813	+4%	+$15.6K	0.89%	33
2019 Q2	$422K	Buy	18,856 +15,928	+544%	+$771K	0.33%	50
2019 Q1	$200K	Buy	+2,928	New	+$188K	0.1%	82
2018 Q3	–	Sell	-1,138	Closed	-$135K	–	159
2018 Q2	$135K	Sell	1,138 -1,362	-54%	-$137K	0.05%	120
2018 Q1	$207K	Buy	+2,500	New	+$283K	0.08%	119

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Telemetry Investments's SRRA Position: Q3 2022 in Review

Telemetry Investments sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 10,046 shares — an estimated $552K sold.

Telemetry Investments first reported a position in SRRA in Q1 2018 and held it in 9 quarters. The position peaked at $552K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Telemetry Investments reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Telemetry Investments sold 10,046 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $552K.
Telemetry Investments first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
Telemetry Investments's Sierra Oncology, Inc. Common Stock position peaked at $552K in Q2 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Telemetry Investments's 13F filing for Q3 2022, filed 17 Nov 2022.